Delivery of an adenoviral vector to the crushed recurrent laryngeal nerve

Laryngoscope

Volumn 113, Issue 6, 2003, Pages 985-989

  Rubin, Adam ^a   Mobley, Bret ^b   Hogikyan, Norman ^a   Bell, Kimberly ^b   Sullivan, Kelli ^b   Boulis, Nicholas ^b,c   Feldman, Eva ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Gene therapy; Nerve injury; Recurrent laryngeal nerve; Retrograde transport; Viral vectors

Indexed keywords

ACETYLCHOLINE; ADENOVIRUS VECTOR; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOCHEMISTRY; NERVE CELL LESION; NERVE CRUSH; NERVE ENDING; NERVE FIBER; NERVE INJURY; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT LARYNGEAL NERVE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; AXONAL TRANSPORT; BRAIN STEM; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; IMMUNOENZYME TECHNIQUES; MOTOR ENDPLATE; NERVE CRUSH; NERVE FIBERS; RATS; RATS, SPRAGUE-DAWLEY; RECURRENT LARYNGEAL NERVE; VOCAL CORD PARALYSIS;

EID: 0038660954     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200306000-00013     Document Type: Article

References (39)

1. Eisele D. Complications of thyroid surgery. In: Eisele D, ed. Complications in Head Neck Surgery. St. Louis: Mosby-Year Book, 2000:423-437.
2. Netterville JL, Aly A, Ossoff RH. Evaluation and treatment of complications of thyroid and parathyroid surgery. Otolaryngol Clin North Am 1990;23:529-552.
3. Goding GS Jr. Nerve-muscle pedicle reinnervation of the paralyzed vocal cord. Otolaryngol Clin North Am 1991;24: 1239-1252.
4. Horn KL, Crumley RL. The physiology of nerve injury and repair. Otolaryngol Clin North Am 1984;17:321-333.
5. Jacobs IN, Sanders I, Wu BL, Biller HF. Reinnervation of the canine posterior cricoarytenoid muscle with sympathetic preganglionic neurons. Ann Otol Rhinol Laryngol 1990;99: 167-174.
6. Hogikyan ND, Johns MM, Kileny PR, Urbanchek M, Carroll WR, Kuzon WM Jr. Motion-specific laryngeal reinnervation using muscle-nerve-muscle neurotization. Ann Otol Rhinol Laryngol 2001;110:801-810.
7. Singleton JR, Dixit VM, Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 1996;271:31791-31794.
8. Kim B, Leventhal PS, Saltiel AR, Feldman EL. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires MAP kinase activation. J Biol Chem 1997;272:21268-21273.
9. Russell JW, Windebank AJ, Schenone A, Feldman EL. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 1998;36:455-467.
10. Baumgartner BJ, Shine HD. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 1997;17:6504-6511.
11. Gimenez Y, Ribotta M, Revah F, et al. Prevention of motor neuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 1997;48:281-285.
12. Lewin GR. Neurotrophic factors and pain. Semin Neurosci 1995;7:227-232.
13. Dittrich FH, Thoenen H, Sendtner M. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol 1994;35:151-163.
14. Kang UJ. Genetic modification of cells with retrovirus vectors for grafting into the central nervous system. In: Kaplitt MG, Loewy AD, eds. Viral Vectors: Gene Therapy and Neuroscience Applications. San Diego: Academic, 1995:211-237.
15. Neve RL. Adenovirus vectors enter the brain. Trends Neurosci 1993;16:252-253.
16. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev 1993;3:499-503.
17. Boulis NM, Bhatia V, Brindle TI, et al. Adenoviral nerve growth factor and β-galactosidase transfer to spinal cord: a behavioral and histological analysis. J Neurosurg (Spine 1) 1998;90:99-108.
18. Liu Y, Himes BT, Moul J, et al. Application of recombinant adenovirus for in vivo gene delivery to spinal cord. Brain Res 1997;768:19-29.
19. Davidson BL, Doran SE, Shewach DS, Latta JM, Hartman JW, Rowssler BJ. Expression of E coli β-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp Neurol 1994;125:258-267.
20. Peel AL, Klein RL. Adeno-associated virus vectors: activity and applications in the CNS. J Neurosci Methods 2000;98:95-104.
21. Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther 1997;4:16-24.
22. Ilan Y, Droguett G, Chowdhury NR, et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci U S A 1997;94:2587-2592.
23. Hartigan-O'Connor D, Amalfitano A, Chamberlain JS. Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase. J Virol 1999;73:7835-7841.
24. Wickham TJ. Targeting adenovirus. Gene Ther 2000;7: 110-114.
25. Boulis NM, Bhatia V, Anlar B, et al. Retrograde adenoviral gene delivery to rat spinal cord via sciatic nerve microinjection. Soc Neurosci Abstr 1998;24:1308.
26. Ghadge GD, Roos RP, Kang UJ, et al. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 1995;2:132-137.
27. Rubin AD, Hogikyan ND, Sullivan K, Boulis N, Feldman EL. Remote delivery of rAAV-GFP to the rat brainstem via the recurrent laryngeal nerve. Laryngoscope 2001;111: 2041-2045.
28. Shiotani A, O'Malley BW Jr, Coleman ME, Flint PW. Human insulinlike growth factor 1 gene transfer into paralyzed rat larynx: single vs multiple injection. Arch Otolaryngol Head Neck Surg 1999;125:555-560.
29. Boulis NM, Turner DE, Dice JA, Bhatia V, Feldman EL. Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery 1999;45:131-138.
30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1982.
31. Falini B, Taylor CR. New developments in immunoperoxidase techniques and their application. Arch Pathol Lab Med 1983;107:105-117.
32. Taylor C. Immunoperoxidase techniques. Arch Pathol Lab Med 1978;102:113-121.
33. Bridge PM, Ball DJ, Mackinnon SE, et al. Nerve crush injuries: a model for axonotmesis. Exp Neurol 1994;127:284-290.
34. Mu L, Yang S. An experimental study on the laryngeal electromyography and visual observations in varying types of surgical injuries to the unilateral recurrent laryngeal nerve in the neck. Laryngoscope 1991;101:699-708.
35. Pestronk A, Drachman DB. A new stain for quantitative measurement of sprouting at neuromuscular junctions. Muscle Nerve 1978;1:70-74.
36. Romero MI, Smith GM. Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade. Gene Ther 1998;5:1612-1621.
37. Peltekian E, Parrish E, Bouchard C, Peschanski M, Lisovoski F. Adenovirus-mediated gene transfer to the brain: methodological assessment. J Neurosci Methods 1997;71:77-84.
38. Turner DE, Noordmans AJ, Feldman EL, Boulis NM. Remote adenoviral gene delivery to the spinal cord: contralateral delivery and reinjection. Neurosurgery 2001;48:1309-1317.
39. Breakefield XO. Gene delivery into the brain using virus vectors. Nat Genet 1993;3:187-189.